Mural Oncology plc Annual Operating Income (Loss) in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Mural Oncology plc quarterly/annual Operating Income (Loss) history and growth rate from 2022 to 2023.
  • Mural Oncology plc Operating Income (Loss) for the quarter ending June 30, 2024 was -$34.3M, a 27.5% increase year-over-year.
  • Mural Oncology plc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$173M.
  • Mural Oncology plc annual Operating Income (Loss) for 2023 was -$196M, a 6.12% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$196M -$11.3M -6.12% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 -$185M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.